Quantum-Si Incorporated (QSI) announced a key milestone in its Proteus™ single-molecule protein sequencing platform, having successfully demonstrated the detection of 19 out of 20 common amino acids. This progress strengthens the company's confidence in its development timeline ahead of the platform's planned commercial launch.
Key Details
- Technological Milestone: The company successfully demonstrated the detection of 19 amino acids in its Proteus™ development program, an advancement over the 18-amino-acid detection capability previously presented.
- Future Outlook: QSI remains confident in its ability to demonstrate the detection of all 20 amino acids by year-end 2026.
- Commercialization Timeline: This progress supports the company's plan for a commercial launch of the Proteus platform in the second quarter of 2027.